Daiichi Sankyo Looks At Consolidating Stake In Zenotech; Minority Shareholders, Founder Cry Hoarse
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Daiichi Sankyo, the majority equity holder in India's largest drug company Ranbaxy, has encountered a hurdle in its proposal to make an open offer for 20 percent shares in Zenotech Labs. Shareholders of Zenotech Labs have pleaded that the open offer price fixed by Daiichi Sankyo is far less than what Ranbaxy paid to acquire 46 percent of its equity a year ago
You may also be interested in...
India's Zenotech Ups Noise Against Daiichi Sankyo; Demands $20 Million In Damages
MUMBAI - The founders of India's emerging oncology and biologics company Zenotech Labs have alleged that Japanese firm Daiichi Sankyo - which holds a 47 percent equity stake in the company - destroyed the value of the company besides delaying clinical trials of one of its key oncology drugs and claiming Zenotech's product trademarks as its own. Zenotech has claimed $20 million in damages from Daiichi Sankyo at an Indian court of law
India's Zenotech Ups Noise Against Daiichi Sankyo; Demands $20 Million In Damages
MUMBAI - The founders of India's emerging oncology and biologics company Zenotech Labs have alleged that Japanese firm Daiichi Sankyo - which holds a 47 percent equity stake in the company - destroyed the value of the company besides delaying clinical trials of one of its key oncology drugs and claiming Zenotech's product trademarks as its own. Zenotech has claimed $20 million in damages from Daiichi Sankyo at an Indian court of law
Daiichi Sankyo Records ¥354 Billion Valuation Loss From Price Drop In Ranbaxy Shares
Daiichi Sankyo announced Jan. 5 a valuation loss of ¥354 billion for the fiscal quarter ending Dec. 31; the loss is associated with a more than 50 percent price drop in Ranbaxy shares the company acquired. With the loss, it is viewed that the company will report a loss in consolidated profit for the fiscal year ending March 31. Daiichi has previously estimated ¥65 billion in profit. It will be the first loss for the company since the merger of Daiichi and Sankyo in 2005. (Click here for more - Japanese language